Kirkland & Ellis represented LucyRx in Abarca Health combination
The combined entity will serve over 9 million members in the US, pending regulatory approvals.
See the latest news and media coverage for Kirkland & Ellis. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global law firm
kirkland.comLast updated
In short: Kirkland & Ellis managed multi-billion dollar transactions and launched a major $500 million AI initiative while expanding into the Tokyo market.
The combined entity will serve over 9 million members in the US, pending regulatory approvals.
Clearlake's eighth flagship fund received $14.8B in commitments from nearly 300 investors globally and will focus on AI and digital transformation.
The carve-out sale to Pollen Street Capital is subject to regulatory approvals.
The acquisition complements AbbVie's immunology portfolio, with AbbVie paying $135.11 per share cash, expected to close in Q3 2026.
Kirkland & Ellis is inching back the curtain on its $500 million artificial intelligence investment, revealing the scale of its technology team and the strategic...
Kirkland & Ellis and Latham & Watkins both broke through the $1bn barrier for London office revenue for the first time ever last year, new...
Applied Aerospace & Defense Inc., with a market value of $3.4 billion, began trading publicly on the New York Stock Exchange on Wednesday after raising...
Kirkland & Ellis has committed $500 million over the next three to four years to develop its own proprietary artificial intelligence platform, according to a...
Track Kirkland & Ellis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Kirkland & Ellis and other trending companies.